Testing FH-006 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new drug called FH-006 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 75 years old.
- Your cancer has spread (metastatic) or come back (recurrent) and you have tried standard treatments that didn't work, or no standard treatment is available.
- You are able to care for yourself (ECOG score 0 or 1) and your doctor expects you to live at least 3 more months.
- You have at least one tumor that can be measured on a scan (like CT or MRI).
- Your major organs (like heart, liver, kidneys) are working well enough.
- You have not had other cancer in the last 5 years, no active brain metastases, no serious autoimmune disease, and no recent infections or surgeries.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called FH-006 for people with advanced solid tumors that cannot be surgically removed or have spread. It aims to see if the drug is safe and effective.
This trial tests a new drug called FH-006 combined with other cancer therapies for people with advanced non-small cell lung cancer that cannot be removed with surgery or treated with radiation. It aims to see if this combination can help shrink tumors or slow cancer growth.
This trial tests an experimental drug called MHB046C for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it can shrink tumors or slow their growth.
This trial studies a new drug called HW071021 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug can help shrink or control the cancer.
This trial tests a new drug called HS-20122 in people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and effective.
This study tests a new drug called HC006 for advanced solid tumors that no longer respond to standard treatments. It aims to find a safe dose and see if it helps shrink tumors.
Hear when a new Malignant Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.